Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (54)
Leukemia (19)
British Journal of Cancer (4)
Nature Medicine (3)
Scientific Reports (3)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (75)
Correspondence (8)
Special Features (7)
Amendments and Corrections (3)
Comments & Opinion (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biological techniques
Biomarkers
Biotechnology
Cancer
Cell biology
Chemical biology
Diseases
Drug discovery
Endocrinology
Genetics
Health care
Immunology
Medical research
Molecular biology
Neurology
Neuroscience
Physiology
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 51–94 of 94 results

Advanced filters: Author: D W Beelen Clear advanced filters

Allogeneic CD34-enriched peripheral blood stem cell transplantation in a patient with paroxysmal nocturnal haemoglobinuria

M Ditschkowski
R Trenschel
D W Beelen
Research03 Sept 2003
Bone Marrow Transplantation

Volume: 32, P: 633-635
Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension

T Scheltens
M L Bots
A W Hoes
Research30 Nov 2006
Journal of Human Hypertension

Volume: 21, P: 99-106
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia

E Lengfelder
A Reichert
T Büchner
Research04 Aug 2000
Leukemia

Volume: 14, P: 1362-1370
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

E. Domingo-Domenech
R. F. Duarte
S. Montoto
Research08 Jan 2021
Bone Marrow Transplantation

Volume: 56, P: 1391-1401
Circulating metabolites modulated by diet are associated with depression

Ashley van der Spek
Isobel D. Stewart
Najaf Amin
ResearchOpen Access26 Jul 2023
Molecular Psychiatry

Volume: 28, P: 3874-3887
Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia

O Maywald
M Pfirrmann
A Reiter
Research02 Feb 2006
Leukemia

Volume: 20, P: 477-484
NEIL1 and NEIL2 DNA glycosylases modulate anxiety and learning in a cooperative manner in mice

Gunn Hildrestrand, Veslemøy Rolseth, and Nicolas Kunath et al. examine mice lacking the NEIL1 and NEIL2 DNA glycosylases involved in base excision repair. Their results suggest that loss of both NEIL1 and NEIL2 dysregulates genes relevant to synaptic function and modulates behavior in mice.

Gunn A. Hildrestrand
Veslemøy Rolseth
Magnar Bjørås
ResearchOpen Access02 Dec 2021
Communications Biology

Volume: 4, P: 1-14
What is the impact of HLA mismatches detected by high-resolution techniques on the outcome of unrelated donor bone marrow transplantation?

H D Ottinger
D W Beelen
H Grosse-Wilde
Correspondence18 Apr 2005
Bone Marrow Transplantation

Volume: 35, P: 1211
Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

M Robin
R Porcher
N Kroger
Amendments and Corrections05 Jul 2017
Bone Marrow Transplantation

Volume: 52, P: 1081
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

D W Beelen
R Trenschel
E Holler
Research13 Dec 2004
Bone Marrow Transplantation

Volume: 35, P: 233-241
MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease

L Kordelas
V Rebmann
B Giebel
Correspondence09 Apr 2014
Leukemia

Volume: 28, P: 970-973
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning

J Casper
J Holowiecki
D W Beelen
Research12 Dec 2011
Bone Marrow Transplantation

Volume: 47, P: 1171-1177
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

U Krug
W E Berdel
T Büchner
Research09 Feb 2016
Leukemia

Volume: 30, P: 1230-1236
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

R Hehlmann
M Lauseker
J Hasford
ResearchOpen Access14 Aug 2017
Leukemia

Volume: 31, P: 2398-2406
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

M Fiegl
M Unterhalt
W Hiddemann
Research22 Oct 2013
Leukemia

Volume: 28, P: 1001-1007
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

H Pfeifer
B Wassmann
O G Ottmann
Research05 Dec 2012
Leukemia

Volume: 27, P: 1254-1262
Hematopoietic stem cell transplantation for hematological malignancies in Europe

A Gratwohl
H Baldomero
A Urbano-Ispizua
Research15 May 2003
Leukemia

Volume: 17, P: 941-959
Additive antileukemia effects by GFI1B- and BCR–ABL-specific siRNA in advanced phase chronic myeloid leukemic cells

M Koldehoff
J L Zakrzewski
A H Elmaagacli
ResearchOpen Access21 Jun 2013
Cancer Gene Therapy

Volume: 20, P: 421-427
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

F Heinzelmann
W Bethge
H Ottinger
Research08 Feb 2016
Bone Marrow Transplantation

Volume: 51, P: 654-662
Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells

M Koldehoff
D W Beelen
A H Elmaagacli
Research06 Jun 2014
Cancer Gene Therapy

Volume: 21, P: 275-282
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma

M Schmidt-Hieber
I W Blau
J Casper
Research19 Feb 2007
Bone Marrow Transplantation

Volume: 39, P: 389-396
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

R Zeiser
A Burchert
N von Bubnoff
Research31 Jul 2015
Leukemia

Volume: 29, P: 2062-2068
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

A Gratwohl
M Pfirrmann
R Hehlmann
ResearchOpen Access14 Oct 2015
Leukemia

Volume: 30, P: 562-569
αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation

L Kordelas
U Buttkereit
D W Beelen
CorrespondenceOpen Access04 Sept 2017
Bone Marrow Transplantation

Volume: 52, P: 1668-1670
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome

N Kröger
R Brand
T de Witte
Research21 Nov 2005
Bone Marrow Transplantation

Volume: 37, P: 183-189
Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors

M Lindemann
M Koldehoff
D W Beelen
Correspondence26 Oct 2015
Bone Marrow Transplantation

Volume: 51, P: 428-431
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

M Robin
R Porcher
N Kroger
Research07 Nov 2016
Bone Marrow Transplantation

Volume: 52, P: 209-215
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia

S Piemontese
F Ciceri
M Mohty
Research01 Dec 2014
Leukemia

Volume: 29, P: 1069-1075
Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis

Christian R. Schultze-Florey
Christophe Peczynski
Grzegorz W. Basak
Correspondence06 Nov 2019
Bone Marrow Transplantation

Volume: 55, P: 1642-1646
Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT

M Ditschkowski
C Haferlach
D W Beelen
Correspondence23 Feb 2009
Bone Marrow Transplantation

Volume: 44, P: 265-266
Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantation

T Gromke
A H Elmaagacli
D W Beelen
Correspondence22 Oct 2012
Bone Marrow Transplantation

Volume: 48, P: 732-733
Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group

J S Floyd
C M Sitlani
B H Stricker
Research13 Dec 2016
The Pharmacogenomics Journal

Volume: 18, P: 127-135
Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology

A A Seyerle
C M Sitlani
C L Avery
Research18 Jul 2017
The Pharmacogenomics Journal

Volume: 18, P: 215-226
Genetic variation in the obesity gene FTO is not associated with decreased fat oxidation: the NEO study

L L Blauw
R Noordam
P C N Rensen
Research19 Jun 2017
International Journal of Obesity

Volume: 41, P: 1594-1600
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann
Astghik Voskanyan
J. Mayer
Amendments and Corrections10 Sept 2020
Leukemia

Volume: 34, P: 2823
Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

C Koenecke
D Heim
N Kröger
Correspondence25 Apr 2016
Bone Marrow Transplantation

Volume: 51, P: 1259-1261
The EBMT activity survey 2009: trends over the past 5 years

H Baldomero
M Gratwohl
K Frauendorfer
Special Features28 Feb 2011
Bone Marrow Transplantation

Volume: 46, P: 485-501
The EBMT activity survey: 1990–2010

J R Passweg
H Baldomero
A Madrigal
Special Features30 Apr 2012
Bone Marrow Transplantation

Volume: 47, P: 906-923
The EBMT activity survey 2008: impact of team size, team density and new trends

A Gratwohl
H Baldomero
D Niederwieser
Special Features29 Mar 2010
Bone Marrow Transplantation

Volume: 46, P: 174-191
The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

A Gratwohl
H Baldomero
D Niederwieser
Special Features26 Jan 2009
Bone Marrow Transplantation

Volume: 43, P: 275-291
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

A Gratwohl
H Baldomero
D Niederwieser
Special Features17 Dec 2007
Bone Marrow Transplantation

Volume: 41, P: 687-705
Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

A Gratwohl
H Baldomero
D Niederwieser
Special Features10 Jan 2007
Bone Marrow Transplantation

Volume: 39, P: 71-87
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

A Gratwohl
R Brand
C Cordonnier
Special Features05 Sept 2005
Bone Marrow Transplantation

Volume: 36, P: 757-769
Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

B Wassmann
H Pfeifer
OG Ottmann
Comments & Opinion26 Nov 2002
Leukemia

Volume: 16, P: 2358-2365

Previous page
page 1
page 2
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited